The Journal of dermatological treatment

Keyphrases

Publications

volume 34, number 1, 2023

Thomas Bieber, Norito Katoh, Eric L Simpson, Marjolein de Bruin-Weller, Diamant Thaçi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P Thyssen
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials. The Journal of dermatological treatment 34 (1) (2023)
Adam Reich, Catherine Reed, Christopher Schuster, Camille Robert, Tamas Treuer, Ennio Lubrano
Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016-2021. The Journal of dermatological treatment 34 (1) (2023)
Jessica A Kern, Amir A Amanullah, Dev Ram Sahni, Jason G Mathis, Christopher M Hull, Douglas L Powell, Aaron M Secrest
Granulomatous cheilitis - is there a role for allergen screening and avoidance? The Journal of dermatological treatment 34 (1) (2023)
Zoe D Draelos
Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies. The Journal of dermatological treatment 34 (1) (2023)
Qi Yin, Frank B Niessen, Susan Gibbs, Oren Lapid, Juliette M I Louter, Paul P M van Zuijlen, Albert Wolkerstorfer
Intralesional corticosteroid administration in the treatment of keloids: a survey among Dutch dermatologists and plastic surgeons. The Journal of dermatological treatment 34 (1) (2023)
Juan M Segura Palacios, Alberto Soto Moreno, Ismael Valladares Millán, Francisco Rivas Ruiz, Carlos Cuenca Barrales, Alejandro Molina Leyva
Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa. The Journal of dermatological treatment 34 (1) (2023)
Luca Mastorino, F Gelato, P Quaglino, M Ortoncelli, Simone Ribero
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, Paola Facheris, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience. The Journal of dermatological treatment 34 (1) (2023)
Lara S van der Schoot, J J Janssen, M T Bastiaens, A de Boer-Brand, C Christiaansen-Smit, D N H Enomoto, R Hovingh, R A Tupker, M M B Seyger, L M Verhoef, J M P A van den Reek, E M G J de Jong
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice. The Journal of dermatological treatment 34 (1) (2023)
Diem-Phuong D Dao, Caitlin G Purvis, Steven R Feldman
Does hospitalization, independent of other treatment, improve severe chronic skin conditions? The Journal of dermatological treatment 34 (1) (2023)
Diego Orsini, Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, Mario Valenti, Chiara Perugini, Alessia Pacifico, Fabio S Maramao, Pasquale Frascione, Antonio Costanzo, Alessandra Narcisi
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers. The Journal of dermatological treatment 34 (1) (2023)
Sydney Thai, Joe Zhuo, Yichen Zhong, Qian Xia, Xiu Chen, Ying Bao, Devender Dhanda, Lawshia Priya, Jashin J Wu
Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies. The Journal of dermatological treatment 34 (1) (2023)
Martina Maurelli, Giampiero Girolomoni, Paolo Gisondi
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience. The Journal of dermatological treatment 34 (1) (2023)
Paolo Gisondi, David Simon, Ivette Alarcon, Effie Pournara, Lluis Puig
Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review. The Journal of dermatological treatment 34 (1) (2023)
Hye Sung Han, Young Gue Koh, Jun Ki Hong, Yoon Jin Roh, Seong Jun Seo, Kui Young Park
Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Valentine Marchal, Ziad Reguiai
Efficacity of dupilumab in severe idiopathic cold urticaria: a case report. The Journal of dermatological treatment 34 (1) (2023)
Faizan Mazhar, Åsa Krantz, Lovisa Schalin, Josefin Lysell, Juan Jesus Carrero
Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice. The Journal of dermatological treatment 34 (1) (2023)
Jashin J Wu, Ching An Wang, Greeta Jobson, David Davidson, Samaneh Kalirai, Julia Zhu, Manasi Suryavanshi, Mayank Mittal, Vardhaman Patel, Lauren Seigel
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis. The Journal of dermatological treatment 34 (1) (2023)
Xing Fan, Tong Li, Xi Zhang, Juan Yang, Jiangbo Cui, Wenjie Dou, Yue Yin, Qing Yang, Ping Xue, Bin Liu, Yang Li
A new method to treat onychopapilloma with pulsed dye laser irradiation: a 13-case series report. The Journal of dermatological treatment 34 (1) (2023)
Kevin V Kwee, Jean-Luc Murk, Qiqi Yin, M Birgitte Visch, Linda Davidson, Elke M G J de Jong, Juul M P A van den Reek, Milan Tjioe
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID). The Journal of dermatological treatment 34 (1) (2023)
Xiao-Ting Song, Zirui Chen, Zuo-Tao Zhao, Aiping Wang
Treatment of generalized granuloma annulare with dupilumab. The Journal of dermatological treatment 34 (1) (2023)
Diem-Phuong D Dao, Caitlin G Purvis, Steven R Feldman
Does hospitalization, independent of other treatment, improve severe chronic skin conditions? The Journal of dermatological treatment 34 (1) (2023)
Astrid M van Huizen, N J Rietbergen, G E van der Kraaij, Dirk T Ubbink, Phyllis I Spuls
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis - a pilot study. The Journal of dermatological treatment 34 (1) (2023)
Juan M Segura Palacios, Alberto Soto Moreno, Ismael Valladares Millán, Francisco Rivas Ruiz, Carlos Cuenca Barrales, Alejandro Molina Leyva
Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa. The Journal of dermatological treatment 34 (1) (2023)
Xiao-Ting Song, Zirui Chen, Zuo-Tao Zhao, Aiping Wang
Treatment of generalized granuloma annulare with dupilumab. The Journal of dermatological treatment 34 (1) (2023)
Angela Londoño García, Andrea Arango Salgado, María de la Luz Orozco-Covarrubias, Angela Marie Jansen, Mariana Rico-Restrepo, María Cecilia Riviti, Margarita María Velásquez-Lopera, Carla Castro
The landscape of vitiligo in Latin America: a call to action. The Journal of dermatological treatment 34 (1) (2023)
Diem-Phuong D Dao, Jessica N Pixley, Steven R Feldman
When should systemic biologic therapy for psoriasis be discontinued? The Journal of dermatological treatment 34 (1) (2023)
Zoe Diana Draelos, Emil A Tanghetti, Leon H Kircik, Neal Bhatia, Joshua A Zeichner, Jeffrey L Sugarman, Linda Stein Gold
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials. The Journal of dermatological treatment 34 (1) (2023)
Luca Mastorino, F Gelato, P Quaglino, M Ortoncelli, Simone Ribero
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Alexander Egeberg, Denis Jullien, Kristian Gaarn Du Jardin, Diamant Thaçi
Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special interest. The Journal of dermatological treatment 34 (1) (2023)
Valentine Marchal, Ziad Reguiai
Efficacity of dupilumab in severe idiopathic cold urticaria: a case report. The Journal of dermatological treatment 34 (1) (2023)
Guido Mioso, Laura Gnesotto, Irene Russo, Stefano Piaserico, Mauro Alaibac
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma. The Journal of dermatological treatment 34 (1) (2023)
Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Jessica Avagliano, Andrea Cortese, Antonio Costanzo, Alessandra Narcisi
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series. The Journal of dermatological treatment 34 (1) (2023)
Jacob P Thyssen, Thomas Bieber, C Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto, Elisabeth Riedl, Andreas Wollenberg
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Jessica A Kern, Amir A Amanullah, Dev Ram Sahni, Jason G Mathis, Christopher M Hull, Douglas L Powell, Aaron M Secrest
Granulomatous cheilitis - is there a role for allergen screening and avoidance? The Journal of dermatological treatment 34 (1) (2023)
Olivia Lamberg, Arianna Strome, Foster Jones, Julia Mleczek, Adrienne Jarocki, Jonathon P Troost, Yolanda Helfrich
Ocular side effects of systemic isotretinoin - a systematic review and summary of case reports. The Journal of dermatological treatment 34 (1) (2023)
Guido Mioso, Laura Gnesotto, Irene Russo, Stefano Piaserico, Mauro Alaibac
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma. The Journal of dermatological treatment 34 (1) (2023)
Kelley Myers, Jonathan I Silverberg, Shreekant Parasuraman, Anna Pierce, Lawrence F Eichenfield, Christine Poulos
Treatment preferences among patients with mild-to-moderate atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
April W Armstrong, Manish Patel, Chao Li, Vishvas Garg, Monika Rao Mandava, Jashin J Wu
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. The Journal of dermatological treatment 34 (1) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Jessica A Kern, Amir A Amanullah, Dev Ram Sahni, Jason G Mathis, Christopher M Hull, Douglas L Powell, Aaron M Secrest
Granulomatous cheilitis - is there a role for allergen screening and avoidance? The Journal of dermatological treatment 34 (1) (2023)
Shawn G Kwatra, Peter A Lio, Stephan Weidinger, Brian M Calimlim, Barry Ladizinski, Namita Vigna, Willings Botha, Carol A Mansfield
Patient preferences for atopic dermatitis treatments: a discrete choice experiment. The Journal of dermatological treatment 34 (1) (2023)
Astrid M van Huizen, N J Rietbergen, G E van der Kraaij, Dirk T Ubbink, Phyllis I Spuls
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis - a pilot study. The Journal of dermatological treatment 34 (1) (2023)
Lara S van der Schoot, J J Janssen, M T Bastiaens, A de Boer-Brand, C Christiaansen-Smit, D N H Enomoto, R Hovingh, R A Tupker, M M B Seyger, L M Verhoef, J M P A van den Reek, E M G J de Jong
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice. The Journal of dermatological treatment 34 (1) (2023)
Diego Orsini, Paolo Iacovelli, Pasquale Frascione, Alessia Pacifico
Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report. The Journal of dermatological treatment 34 (1) (2023)
Shiyu Zhang, Lu Lu, Jindi Feng, Zhonghui Hu, Hongbin Song, Lu Yang, Yuehua Liu, Di Chen, Tao Wang
Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient. The Journal of dermatological treatment 34 (1) (2023)
Angela Leigh-Ann L Bosma, Louise A A Gerbens, Hajar El Khattabi, Floris C Loeff, Michael Duckworth, Richard T Woolf, Theo Rispens, Catherine H Smith, Phyllis I Spuls
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study. The Journal of dermatological treatment 34 (1) (2023)
Lara S van der Schoot, J J Janssen, M T Bastiaens, A de Boer-Brand, C Christiaansen-Smit, D N H Enomoto, R Hovingh, R A Tupker, M M B Seyger, L M Verhoef, J M P A van den Reek, E M G J de Jong
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice. The Journal of dermatological treatment 34 (1) (2023)
Francisco Javier de la Torre Gomar, Javier Gimeno Castillo, Pau Rosés Gibert, Erika Iglesias Martínez, Maria Isabel Martínez González
Silicone-induced granulomas successfully treated with adalimumab. The Journal of dermatological treatment 34 (1) (2023)
Hyeokjae Kwon, Seokui Lee, Jiyoung Kim, Seung Han Song
Efficacy and safety of stromal vascular fraction on scar revision surgery: a prospective study. The Journal of dermatological treatment 34 (1) (2023)